Grufity logo
Grufity logo

Latest StemPoint Capital LP Stock Portfolio

$1.04Billion | No. of Holdings #70

StemPoint Capital LP Performance

2026 Q1+1.72%
YTD+1.72%
2025+28.89%

About StemPoint Capital LP and 13F Hedge Fund Stock Holdings

On 2026-05-18, the fund reported it's updated stock portfolio. In the 13F Holdings report, STEMPOINT CAPITAL LP reported an equity portfolio of $1 Billions as of 31 Mar, 2026. <br><br> The top stock holdings of STEMPOINT CAPITAL LP are SRRK, , SNDX. The fund has invested 9.8% of it's portfolio in SCHOLAR ROCK HLDG CORP and 6.7% of portfolio in ABIVAX SA. <br><br> The fund managers got completely rid off CENTESSA PHARMACEUTICALS PLC (CNTA), ARCELLX INC (ACLX) and MADRIGAL PHARMACEUTICALS INC (MDGL) stocks. They significantly reduced their stock positions in TWIST BIOSCIENCE CORP (TWST), ROIVANT SCIENCES LTD (ROIV) and XENON PHARMACEUTICALS INC (XENE). STEMPOINT CAPITAL LP opened new stock positions in ENLIVEN THERAPEUTICS INC, CELLDEX THERAPEUTICS INC NEW (CLDX) and TYRA BIOSCIENCES INC (TYRA). The fund showed a lot of confidence in some stocks as they added substantially to MBX BIOSCIENCES INC, SPYRE THERAPEUTICS INC (AGLE) and REVOLUTION MEDICINES INC (RVMD).
StemPoint Capital LP Equity Portfolio Value
Last Reported on: 18 May, 2026
$1.04Billion
  as of May 18, 2026

StemPoint Capital LP Annual Return Estimates Vs S&P 500

Our best estimate is that STEMPOINT CAPITAL LP made a return of 1.72% in the last quarter. In trailing 12 months, it's portfolio return was 45.24%.
  • Performance
  • S&P 500

New Buys

Ticker$ Bought
enliven therapeutics inc28,493,500
cg oncology inc27,833,000
biohaven ltd26,978,800
celldex therapeutics inc new16,130,700
tyra biosciences inc14,797,400
definium therapeutics inc12,303,300
bioage labs inc11,846,100
acadia pharmaceuticals inc10,799,000
New stocks bought by StemPoint Capital LP

Additions

Ticker% Inc.
mbx biosciences inc1,171
spyre therapeutics inc935
revolution medicines inc808
evommune inc468
praxis precision medicines i434
sab biotherapeutics inc411
newamsterdam pharma company394
eyepoint inc358
Additions to existing portfolio by StemPoint Capital LP

Reductions

Ticker% Reduced
twist bioscience corp-83.37
roivant sciences ltd-20.18
xenon pharmaceuticals inc-19.25
johnson & johnson-11.91
StemPoint Capital LP reduced stake in above stock

Sold off

Ticker$ Sold
palisade bio inc-9,852,080
xilio therapeutics inc-1,299,620
centessa pharmaceuticals plc-28,864,400
cytomx therapeutics inc-4,414,680
arbutus biopharma corp-4,746,270
immatics n.v-6,408,230
adaptive biotechnologies cor-9,854,840
ocular therapeutix inc-6,345,490
StemPoint Capital LP got rid off the above stocks

Sector Distribution

STEMPOINT CAPITAL LP has about 67.2% of it's holdings in Healthcare sector.

  • Healthcare
  • Others
Sector%
Healthcare67.2
Others32.3

Market Cap. Distribution

STEMPOINT CAPITAL LP has about 9.4% of it's portfolio invested in the large-cap and mega-cap stocks.

  • MID-CAP
  • UNALLOCATED
  • SMALL-CAP
  • LARGE-CAP
  • MICRO-CAP
  • MEGA-CAP
  • NANO-CAP
Category%
MID-CAP35.1
UNALLOCATED32.3
SMALL-CAP17
LARGE-CAP8
MICRO-CAP5.2
MEGA-CAP1.4
NANO-CAP1.1

Stocks belong to which Index?

About 49.6% of the stocks held by STEMPOINT CAPITAL LP either belong to S&P 500 or RUSSELL 2000 index.

  • RUSSELL 2000
  • Others
Index%
RUSSELL 200049.6
Others49.5
Top 5 Winners (%)%
dianthus therapeutics inc
59.4 %
AADI
whitehawk therapeutics inc
36.1 %
TWST
twist bioscience corp
29.1 %
SRZN
surrozen inc
27.2 %
XENE
xenon pharmaceuticals inc
26.9 %
Top 5 Winners ($)$
SRRK
scholar rock hldg corp
7.6 M
RVMD
revolution medicines inc
5.5 M
dianthus therapeutics inc
5.3 M
ROIV
roivant sciences ltd
5.2 M
TWST
twist bioscience corp
4.8 M
Top 5 Losers (%)%
VSTA
vistagen therapeutics inc
-52.0 %
ADGI
invivyd inc
-36.3 %
structure therapeutics inc
-29.4 %
QURE
uniqure nv
-22.9 %
EYPT
eyepoint inc
-20.3 %
Top 5 Losers ($)$
abivax sa
-12.0 M
structure therapeutics inc
-8.0 M
mineralys therapeutics inc
-6.2 M
EYPT
eyepoint inc
-5.3 M
ARQT
arcutis biotherapeutics inc
-2.9 M

StemPoint Capital LP Holdings Map

This heatmap illustrates the top 50 positions within the fund's portfolio.

Current Stock Holdings of StemPoint Capital LP

STEMPOINT CAPITAL LP has 70 stocks in it's portfolio. About 45.5% of the portfolio is in top 10 stocks. proved to be the most loss making stock for the portfolio. SRRK was the most profitable stock for STEMPOINT CAPITAL LP last quarter.

$1.03BTotal Value
106Positions
18 May, 2026Last Reported
Current holdings of Current Stock Holdings of StemPoint Capital LP, last reported on 18 May, 2026. Select a row with a linked ticker to view its historical trend.
ExpandHoldingsorted ascending% PortfolioShares Held$ Value% Change
ADCT
Adc Therapeutics Sa

Adc Therapeutics Sa

ADCT
StemPoint Capital LP's holding in Adc Therapeutics Sa over time
0%0.00
$0.00
0%
decreased 100 percentsold off
ASND
Ascendis Pharma A/S

Ascendis Pharma A/S

ASND
StemPoint Capital LP's holding in Ascendis Pharma A/S over time
0%0.00
$0.00
0%
decreased 100 percentsold off
BLTE
Belite Bio Inc

Belite Bio Inc

BLTE
StemPoint Capital LP's holding in Belite Bio Inc over time
0%0.00
$0.00
0%
decreased 100 percentsold off